A characteristic feature of the infectious cycles of viruses with DNA genomes is DNA synthesis-dependent activation of transcription of viral late genes. In the case of human adenoviruses, such as adenovirus type 5 (Ad5), replication of the viral genome initiates a two-step transcriptional cascade. Transcription of the viral IVa 2 gene is first activated as a result of viral DNA synthesis-dependent titration of a cellular transcriptional repressor that binds to the IVa 2 promoter (10,27,36). Synthesis of the IVa 2 protein in infected cells then leads to maximally efficient transcription from the major late (ML) promoter, which controls expression of the coding sequences for all but one of the viral structural proteins (58). Entry into the late phase is accompanied by several changes in ML transcription. During the early phase, the ML and other early promoters are utilized with similar efficiencies (57), but ML transcription terminates at multiple sites within a large region in the middle of the transcription unit (1, 2, 28, 57). In contrast, termination occurs close to the right end of the viral genome during the late phase of infection (17). The difference in how much of the ML unit is transcribed, in conjunction with differences in the posttranscriptional processing of ML premRNAs, results in production of only the L1 52/55-kDa protein early in infection but at least 15 ML mRNAs late in infection (15,58). It has also been reported that the processivity of ML transcription beyond approximately position ϩ1,000 increases late in infection (33). Finally, the efficiency of ML transcription increases by a factor of 20 to 30 once viral DNA synthesis has commenced (57).The basal ML promoter comprises a typical TATA sequence, an initiator, GC-rich sequences near the initiator, and binding sites for the cellular proteins USF and CBF located upstream of the TATA sequence (8,11,42,48,50,51,55). Late phase-specific stimulation of ML transcription in vitro and in infected cells requires additional, intragenic sequences, termed DE1 (positions ϩ86 to ϩ96) and DE2 (positions ϩ101 to ϩ116) (29, 34, 41). These DE sequences are recognized by proteins present only in extracts of Ad5-infected cells harvested during the late phase of infection (29,34,44). Previous biochemical studies identified DEF-B, which binds to the DE2 sequence shown in Fig. 1, as a dimer of the IVa 2 protein (38,60). This interaction was shown to stimulate ML transcription in transient-expression assays (60). The DE1 and DE2a sequences of the ML promoter ( Fig. 1) are recognized by a second infected-cell-specific protein, termed DEF-A (30, 43). Initial efforts to purify DEF-A were not successful, although it was reported that the IVa 2 protein is also a component of this . In addition to binding to the ML promoter, the IVa 2 protein recognizes repeated, redundant sequences termed A repeats (20,21,56) within the viral packaging signal (65) and is required for packaging of the viral genome during assembly (46,66,67). This protein is a component of infected-cell-...